Published in J Transl Med on January 22, 2016
Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis. J Gastroenterol (2016) 0.86
Tumour CD274 (PD-L1) expression and T cells in colorectal cancer. Gut (2016) 0.83
Visceral fat adipocytes from obese and colorectal cancer subjects exhibit distinct secretory and ω6 polyunsaturated fatty acid profiles and deliver immunosuppressive signals to innate immunity cells. Oncotarget (2016) 0.82
Body mass index and risk of colorectal cancer according to tumor lymphocytic infiltrate. Int J Cancer (2016) 0.81
Tumor LINE-1 methylation level and colorectal cancer location in relation to patient survival. Oncotarget (2016) 0.81
Signaling Interplay between Bone Marrow Adipose Tissue and Multiple Myeloma cells. Front Endocrinol (Lausanne) (2016) 0.79
Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer. Int J Mol Sci (2017) 0.78
Does obesity promote the development of colorectal cancer? Expert Rev Anticancer Ther (2016) 0.77
Oxidative Stress: A New Target for Pancreatic Cancer Prognosis and Treatment. J Clin Med (2017) 0.75
Regulation of Autophagy-Related Protein and Cell Differentiation by High Mobility Group Box 1 Protein in Adipocytes. Mediators Inflamm (2016) 0.75
Proceedings of the third international molecular pathological epidemiology (MPE) meeting. Cancer Causes Control (2017) 0.75
Nutrient deprivation in neuroblastoma cells alters 4-hydroxynonenal-induced stress response. Oncotarget (2016) 0.75
Tumor SQSTM1 (p62) expression and T cells in colorectal cancer. Oncoimmunology (2017) 0.75
Body mass index and risk of colorectal carcinoma subtypes classified by tumor differentiation status. Eur J Epidemiol (2017) 0.75
ADIPOQ rs266729 G/C gene polymorphism and plasmatic adipocytokines connect metabolic syndrome to colorectal cancer. J Cancer (2017) 0.75
Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status. J Clin Oncol (2017) 0.75
Prevalence of overweight and obesity in the United States, 1999-2004. JAMA (2006) 72.59
Mutations of the BRAF gene in human cancer. Nature (2002) 65.42
Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser (1995) 57.68
Cancer statistics, 2015. CA Cancer J Clin (2015) 57.51
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA (2014) 36.94
Cancer-related inflammation. Nature (2008) 34.21
High frequency of mutations of the PIK3CA gene in human cancers. Science (2004) 27.94
Genetic alterations during colorectal-tumor development. N Engl J Med (1988) 26.82
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet (2008) 20.62
Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest (2007) 20.19
NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol (2005) 13.98
Effects of the obese gene product on body weight regulation in ob/ob mice. Science (1995) 13.57
Weight-reducing effects of the plasma protein encoded by the obese gene. Science (1995) 13.05
Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation (2007) 12.79
Macrophages, inflammation, and insulin resistance. Annu Rev Physiol (2010) 11.77
Inflammatory mechanisms in obesity. Annu Rev Immunol (2011) 9.83
Prevalence of ras gene mutations in human colorectal cancers. Nature (1987) 9.23
Mutation of a mutL homolog in hereditary colon cancer. Science (1994) 9.04
Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature (1994) 8.04
Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature (2002) 7.46
Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J (2003) 7.21
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res (2011) 5.97
p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res (1990) 5.70
Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science (2005) 5.68
Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond) (2008) 5.03
PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol (2009) 4.83
The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat Rev Cancer (2012) 4.72
The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells. Cancer Cell (2005) 4.48
Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst (2000) 4.39
Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol (2012) 4.22
Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev (2011) 4.07
Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut (2010) 4.01
Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc Natl Acad Sci U S A (1998) 3.90
Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res (2010) 3.71
PPARγ signaling and metabolism: the good, the bad and the future. Nat Med (2013) 3.71
Molecular mechanisms of cancer development in obesity. Nat Rev Cancer (2011) 3.65
Insulin and colon cancer. Cancer Causes Control (1995) 3.48
Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med (2002) 3.47
Impact of EGFR expression on colorectal cancer patient prognosis and survival. Ann Oncol (2005) 3.34
Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism (1987) 3.32
Towards the introduction of the 'Immunoscore' in the classification of malignant tumours. J Pathol (2014) 3.21
The predictive value of different measures of obesity for incident cardiovascular events and mortality. J Clin Endocrinol Metab (2010) 3.12
Vegetarian dietary patterns and the risk of colorectal cancers. JAMA Intern Med (2015) 3.09
Cytokine patterns in patients with cancer: a systematic review. Lancet Oncol (2013) 2.92
Overweight as an avoidable cause of cancer in Europe. Int J Cancer (2001) 2.88
Minireview: Obesity and breast cancer: the estrogen connection. Endocrinology (2009) 2.57
Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies. PLoS One (2011) 2.55
Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab (2006) 2.52
AP-1--The Jun proteins: Oncogenes or tumor suppressors in disguise? Cell Signal (2010) 2.49
Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst (1999) 2.40
PTEN: a new guardian of the genome. Oncogene (2008) 2.37
Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol (2014) 2.35
16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer (2011) 2.32
Macrophage polarization to a unique phenotype driven by B cells. Eur J Immunol (2010) 2.25
NSAIDs and cancer prevention: targets downstream of COX-2. Annu Rev Med (2007) 2.19
Free radical lipid peroxidation: mechanisms and analysis. Chem Rev (2011) 2.17
The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis. Acta Oncol (2014) 2.14
Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res (1997) 2.06
The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer. PLoS One (2012) 2.05
Biology of the adenomatous polyposis coli tumor suppressor. J Clin Oncol (2000) 2.03
High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity. Nature (2014) 2.03
Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention. Int J Mol Sci (2013) 2.00
Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst (2010) 1.99
Oxy radicals, lipid peroxidation and DNA damage. Toxicology (2002) 1.98
Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res (2002) 1.96
Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. Mod Pathol (2013) 1.95
Body mass index and colon cancer mortality in a large prospective study. Am J Epidemiol (2000) 1.91
IL-6 and related cytokines as the critical lynchpins between inflammation and cancer. Semin Immunol (2014) 1.89
Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells. J Biol Chem (2003) 1.86
Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management. Fam Cancer (2007) 1.82
BRAFV600E: implications for carcinogenesis and molecular therapy. Mol Cancer Ther (2011) 1.77
Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo. Proc Natl Acad Sci U S A (2005) 1.72
Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression. Annu Rev Med (2012) 1.70
SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. Gastroenterology (2011) 1.67
Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia. Cancer Res (2006) 1.64
Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps. Gastroenterology (2005) 1.58
Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution. Proc Natl Acad Sci U S A (2000) 1.55
Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. Am J Pathol (1998) 1.55
Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res (1986) 1.55
Adipocyte-derived endotrophin promotes malignant tumor progression. J Clin Invest (2012) 1.55
CXCL10 and autoimmune diseases. Autoimmun Rev (2008) 1.49
4-hydroxynonenal as a bioactive marker of pathophysiological processes. Mol Aspects Med (2003) 1.49
Oxidized phospholipids: from molecular properties to disease. Biochim Biophys Acta (2007) 1.47
Diet, lifestyle, and genomic instability in the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev (2005) 1.45
Body size and the risk of colon cancer in a large case-control study. Int J Obes Relat Metab Disord (1998) 1.41
Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer. Cancer Immunol Immunother (2014) 1.39
Aromatase: biologic relevance of tissue-specific expression. Semin Reprod Med (2004) 1.38
Possible mutagens derived from lipids and lipid precursors. Mutat Res (1990) 1.38
Adipokines linking obesity with colorectal cancer risk in postmenopausal women. Cancer Res (2012) 1.35
Body size and colorectal-cancer risk. Int J Cancer (1998) 1.34
Assessing body composition with DXA and bioimpedance: effects of obesity, physical activity, and age. Obesity (Silver Spring) (2008) 1.32
EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1/Sp3 transcription factors in human gliomas. Cancer Res (2007) 1.32
DNA adducts with lipid peroxidation products. J Biol Chem (2008) 1.32
Fusobacterium in colonic flora and molecular features of colorectal carcinoma. Cancer Res (2014) 1.30
Regulation of macrophage phenotype by long-term exposure to IL-10. Immunobiology (2005) 1.27
Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26. Jpn J Cancer Res (1989) 1.26
Interaction between adiponectin and leptin influences the risk of colorectal adenoma. Cancer Res (2010) 1.26